STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?
Open Access
- 1 January 2006
- Vol. 55 (1), 123-130
- https://doi.org/10.1136/gut.2005.069757
Abstract
Hepatic steatosis is a common histological feature of chronic hepatitis C. Various factors are associated with hepatic steatosis, including obesity, high alcohol consumption, diabetes type II, and hyperlipidaemia. These factors may contribute to steatosis in patients with chronic hepatitis C. In humans, hepatitis C virus (HCV) genotype 3 is more commonly associated with steatosis. In vitro studies and the transgenic mouse model have suggested that the HCV core protein (genotype 1) can induce lipid accumulation within hepatocytes. However, what is the relevance of steatosis in chronic hepatitis C? It seems that in certain populations, steatosis may be associated with fibrosis progression and this may be genotype specific. The mechanisms underlying this association are unknown; neither is it clear whether this holds true for all patients or only a subgroup. Indeed, after antiviral treatment, virus related steatosis disappears whereas the host associated steatosis remains unaffected. This review describes and discusses the basic and clinical aspects of the relationship between steatosis and progression of fibrosis, and response to treatment in patients with chronic hepatitis C.Keywords
This publication has 77 references indexed in Scilit:
- Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis CGut, 2003
- High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis CHepatology, 2003
- Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis CHepatology, 2003
- AGA technical review on nonalcoholic fatty liver diseaseGastroenterology, 2002
- Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic responseHepatology, 2002
- Contribution of obesity to hepatitis C-related fibrosis progressionThe American Journal of Gastroenterology, 2002
- Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcoholHepatology, 2002
- Genotype‐specific mechanisms for hepatic steatosis in chronic hepatitis C infectionJournal of Gastroenterology and Hepatology, 2002
- Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis CGut, 2002
- Nonalcoholic fatty liver diseaseGastroenterology, 2002